Target intelligence / Profile preview

Late cornified envelope pseudogene 1 (LCEP1)

Target
LCEP1
Molecular classification
Other (pseudogene)
01

Overview

Late cornified envelope pseudogene 1 (LCEP1) is part of the late cornified envelope (LCE) gene cluster located in the epidermal differentiation complex (EDC) on chromosome 1q21[1][3][5]. The LCE genes are involved in the late stages of epidermal differentiation and barrier formation, with protein-coding LCE genes serving as substrates for transglutaminase-mediated cross-linking during cornified envelope assembly in the skin[1][3]. However, LCEP1 is annotated as a pseudogene and does not encode a functional protein. There is no evidence for its translation or involvement in biological functions, disease, or therapeutic intervention. It is not a current or plausible therapeutic target. Functional members of the LCE gene family encode structural proteins of the cornified envelope, contributing to skin barrier function, but LCEP1 is not included among these functional proteins[1][3]. Pseudogenes such as LCEP1 may be relics of gene duplication or retrotransposition events. They do not produce functional proteins and typically lack regulatory or disease associations unless experimentally demonstrated, which is not the case for LCEP1. The related small proline-rich proteins (SPRRs) and other LCE proteins are investigated for barrier modulation in skin, but not the pseudogene forms[1][3]. There is no evidence from available resources that LCEP1 is an active protein or has roles in drug action, disease biomarker use, or known therapeutic applications[1][3][5].

Other names
small proline rich-like (epidermal differentiation complex) 1B pseudogeneLCEP1
02

Mechanism of action

Not applicable

03

Biological functions

Not applicable (pseudogene; no known biological function)
04

Disease associations

Not applicable (no evidence for direct disease involvement)

Beyond the preview

Go deeper on Late cornified envelope pseudogene 1 (LCEP1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Late cornified envelope pseudogene 1 (LCEP1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call